Gliquidone

Gliquidone

Systematic (IUPAC) name
N-(cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy category	C
Legal status	UK: POM (Prescription only)
Routes of administration	Oral
Pharmacokinetic data
Excretion	95% Biliary, 5% Renal
Identifiers
CAS Number	33342-05-1
ATC code	A10BB08 (WHO)
PubChem	CID: 91610
DrugBank	DB01251 Y
ChemSpider	82719 Y
UNII	C7C2QDD75P Y
KEGG	D02430 Y
ChEMBL	CHEMBL383634 Y
Chemical data
Formula	C27H33N3O6S
Molecular mass	527.634 g/mol
SMILES O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3c(ccc(OC)c3)C(C4=O)(C)C
InChI InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33) Y Key:LLJFMFZYVVLQKT-UHFFFAOYSA-N Y
(verify)

Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehriger Ingelheim, Germany.